IMGN - ImmunoGen, Inc.
Close
31.23
0 0%
Share volume: 0
Last Updated: Fri 09 Feb 2024 10:00:01 PM CET
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
$31.23
0.00
0.00%
Summary score
40%
Profitability
33%
Dept financing
39%
Liquidity
52%
Performance
45%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
37.79%
Return on assets
-7.03%
Return on sales
-147.95%
Return on invested capital
36.85%
Total debt ratio
68.79%
Debt ratio change over timeo
0.29%
Current Ratio
3.53%
Quick Ratio
3.51%
Cash Position Ratio
3.14%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-16.72%
Return on assets
-7.3%
Return on sales
-52.96%
Return on invested capital
26.27%
Total debt ratio
44.01%
Debt ratio change over timeo
0.11%
Current Ratio
4.47%
Quick Ratio
4.41%
Cash Position Ratio
3.71%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
5.48%
Return on assets
3.16%
Return on sales
22.88%
Return on invested capital
-38.7%
Total debt ratio
31.69%
Debt ratio change over time
-1.82%
Current Ratio
5.7%
Quick Ratio
5.65%
Cash Position Ratio
4.5%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-8.06%
Return on assets
-111.77%
Return on sales
-364.31%
Return on invested capital
-27.9%
Total debt ratio
29.48%
Debt ratio change over time
0.29%
Current Ratio
8.28%
Quick Ratio
8.25%
Cash Position Ratio
7.3%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IMGN | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 37.79% | 0% | 0% | -117.6% |
| Return on assets | -7.03% | 0% | 0% | -11.99% |
| Return on sales | -147.95% | 0% | 0% | -8680.79% |
| Return on invested capital | 36.85% | 0% | 0% | -48.11% |
| Profitability | 50% | 0% | 50% | 0% |
| Total debt ratio | 68.79% | 0% | 0% | 77.42% |
| Debt ratio change over time | 0.29% | 0% | 0% | -0.81% |
| Dept financing | 47% | 0% | 0% | 25% |
| Current Ratio | 4.47% | 0% | 0% | 5.35% |
| Quick Ratio | 4.41% | 0% | 0% | 5.34% |
| Cash Position Ratio | 3.71% | 0% | 0% | 5.03% |
| Liquididy | 33% | 0% | 0% | 75% |
| Short-term ratios | IMGN | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -16.72% | 0% | 0% | 146.7% |
| Return on assets | -7.3% | 0% | 0% | -18.66% |
| Return on sales | -52.96% | 0% | 0% | -28500.29% |
| Return on invested capital | 26.27% | 0% | 0% | -371.75% |
| Profitability | 25% | 0% | 50% | 25% |
| Total debt ratio | 44.01% | 0% | 0% | 108.07% |
| Debt ratio change over time | 0.11% | 0% | 0% | -1.53% |
| Dept financing | 35% | 0% | 0% | 25% |
| Current Ratio | 4.47% | 0% | 0% | 5.35% |
| Quick Ratio | 4.41% | 0% | 0% | 5.34% |
| Cash Position Ratio | 3.71% | 0% | 0% | 5.03% |
| Liquididy | 60% | 0% | 0% | 75% |